Deliver Your News to the World

SmallCapNewsRelease: (OTCBB: SPPH) Adds Doctor To Scientific Advisory Board To Further The Company’s Global Expansion


JERICHO, NY—(SmallCapNewsRelease)—October 28th, 2010, Spencer Pharmaceutical Inc. (OTCBB: SPPH) announced today they have added a senior scientist to their Scientific Advisory Board as well as retained him as a business advisor.

Dr. Abderrazzak Merzouki, currently teaching at the Institute of Biomedical Engineering at Ecole Polytechnique de Montreal, will bring a wealth of research knowledge and business connections to the efforts of Spencer Pharmaceuticals.

Spencer Pharmaceuticals develops drug release and absorption systems for the treatment of metabolic diseases, such as diabetes.

A recent study by the International Diabetes Federation estimates that over the next 20 years, diabetes cases worldwide will rise to nearly 350 million.

For more information please visit

To view the entire press release please visit
SmallCapNewsRelease gainers are MER Telemanagement Solutions (NASDAQ: MTSL) RIT Technology Ltd (NASDAQ: RITT) China GrenTech Corp (NASDAQ: GRRF) 3D Systems Corp (NASDAQ: TDSC) Syniverse Holdings Inc (NYSE: SVR) eOn Communications (NASDAQ: EONC) iStar Financial (NYSE: SFI) HMG Courtland Properties (AMEX: HMG)

SmallCapNewsRelease decliners are Flagstar Bancorp (NYSE: FBC) Oclaro Inc (NASDAQ: OCLR) Sourcefire (NASDAQ: FIRE) Clean Diesel Technologies (NASDAQ: CDTID) Navigant Consulting (NYSE: NCI) Integrated Silicon Solutions (NASDAQ: ISSI) Sketchers USA Inc (NYSE: SKX) Finisar Corp (NASDAQ: FNSR)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Small Cap News Release twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation, do no trading of any kind and send no faxes or emails.


 Spencer Pharmaceuticals

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.